Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 297 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-11-03 | 195109 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195112 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-16 | 2023-10-11 | 195207 |
NOVAMOXIN | 500MG | CAPSULE | Resolved | 2023-06-19 | 2023-07-05 | 195410 |
NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2023-06-19 | 2023-08-18 | 195545 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-06-20 | 2023-11-03 | 195754 |
NOVAMOXIN | 500MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195818 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2023-10-19 | 2024-07-03 | 207503 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-04-02 | 95408 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-03-26 | 95411 |
NOVAMOXIN | 250MG | CAPSULE | Resolved | 2020-01-09 | 2020-01-24 | 102938 |
NOVAMOXIN | 50MG | GRANULES FOR SUSPENSION | Resolved | 2020-02-07 | 2020-06-11 | 105596 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-05-19 | 2022-07-01 | 160983 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-08-18 | 2022-09-08 | 167159 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-09-22 | 2024-02-14 | 169966 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-10-20 | 2024-02-14 | 172263 |
NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2022-10-28 | 2023-10-04 | 173046 |
NOVAMOXIN | 500MG | CAPSULE | Resolved | 2022-12-01 | 2023-07-05 | 176767 |
NOVAMOXIN | 250MG | CAPSULE | Resolved | 2022-12-01 | 2023-06-09 | 176770 |
NOVAMOXIN | 500MG | CAPSULE | Resolved | 2020-03-12 | 2020-03-26 | 108610 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253165 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240081 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
TEVA-NAPROXEN SODIUM DS | 550MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81350 |
TEVA-NORFLOXACIN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65013 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63946 |
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-NYSTATIN | 100000UNIT | CREAM | Discontinued | 2020-07-10 | 2020-07-10 | 120056 |
TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-06-28 | 2024-06-29 | 231586 |
TEVA-OXYBUTYNIN | 5MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240078 |
TEVA-PANTOPRAZOLE MAGNESIUM | 40MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-02-12 | 2021-02-12 | 133891 |
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253182 |
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81313 |
TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253160 |
TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100540 |
TEVA-PAROXETINE | 20MG | TABLET | Discontinued | 2019-12-09 | 2019-12-09 | 100547 |
TEVA-PAROXETINE | 10MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106898 |
TEVA-PAROXETINE | 30MG | TABLET | Discontinued | 2020-02-21 | 2020-02-21 | 106901 |
TEVA-PIOGLITAZONE | 45MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65033 |